Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
A new CEO takes over the embattled planemaker. Plus: Elon picks a fight, the Fed might finally cut rates and Microsoft makes a lot of money but not enough.
Will the exercising at home revolution continue in a post-Covid world? Find out what the FlexIt CEO had to say, plus the company's partnership with TalkSpace.